REWIND

Definition

Cardiovascular outcomes for dulaglutide in 9,901 adults with type 2 diabetes (Gerstein et al., Lancet 2019): MACE down 12% over a median 5.4 years. Notable for enrolling a majority who had NOT yet had a cardiovascular event — primary prevention, which is a harder result to get.

REWIND trial deep-dive →

GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature. Not one of them is an AI-generated summary.

Other terms under trial

• SURMOUNT-5
• SURMOUNT-2
• SURMOUNT-3
• SURPASS-2
• SUSTAIN-6
• PIONEER 6
• STEP-HFpEF
• EXSCEL
• ELIXA
• AMPLITUDE-O
• HARMONY OUTCOMES
• SCALE Diabetes
• STEP 2
• SUMMIT
• SCALE Maintenance

Where the evidence lives

• REWIND trial deep-dive
• The full GLP-1 glossary (149 terms, 8 categories)
• Research articles — written from primary sources
• Tools and calculators
• Compare GLP-1 telehealth providers